Moonlake Immunotherapeutics – Investors and Politicians Who Own It
MLTX
Investors who own it
3 tracked investors, $448.3M in shares, each from their latest 13F.
| Investor | Value | Share of portfolio |
|---|---|---|
Mark LampertBVF Partners, Q2 2026 | $311.5M | 7.97% |
David KroinDeep Track Capital, Q2 2026 | $136.3M | 1.98% |
Daniel SchneebergerADAR1 Capital Management, Q2 2026 | $525.7K | 0.02% |
Politicians who own it
Estimated from annual disclosures and trades; values are rough estimates.
No member of Congress is estimated to hold this stock.
Investors buying and selling
| Investor | Action | Shares now |
|---|---|---|
| Mark Lampert | Reduced −9.2% | 19,751,284 |
| Daniel Schneeberger | Reduced −26% | 17,424 |
Politicians trading it
Latest Congress trades disclosed under the STOCK Act; amounts are ranges.
No disclosed Congress trades in this stock.